Download the Final Programme in pdf format.
Click on the presentation / session title to watch the video.
Athens, Greece (EEST) Brussels, Belgium (CEST) Sao Paolo, Brazil (GMT-3) Singapore / Beijing (GMT+8)
Novel nicotine-delivering products: toxicology, regulation, and health issues
Goals of the 3rd Scientific Summit on Tobacco Harm Reduction
|Tobacco Control Policies – Do they work?|
Chairs: Michael G. Toumbis & Karl E. Lund
– Global tobacco control efforts — What has been done so far? Stamatoula Tsikrika
– How are we addressing youth appeal and access? Lion Shahab
– Smoking Cessation: Best practices to improve quit rates, Georgios S. Goumas
– e-Cigarettes for smoking cessation, Paraskevi A. Katsaounou
|Oral Presentations (submitted abstracts) |
Chairs: Anastasia Barbouni, Konstantinos Poulas, Demetrios Kouretas
Epidemiology & Social Issues
Clinical Assessment and Harm Reduction
|Break || Posters Q & A (I) |
1 – Epidemiology & Social Issues (perception risk, attractiveness, etc.)
2 – Toxicology and aerosol chemistry etc
3 – Biomarkers’ evaluation in animal or human studies
4 – Preclinical evaluation
|Keynote lecture |
Risk proportionate regulation and the science to support it: How rapidly can we end the epidemic of cigarette-caused disease? David T. Sweanor J.D.
Chair: Ignatios Ikonomidis
|Public Health Policy and Regulation – What is expected in the future? |
Chairs: Panos E. Vardas & David T. Sweanor J.D.
|Clinical Assessment and Research |
Chairs: Peter Harper & Ignatios Ikonomidis